Composite of coronary heart disease death and non-fatal myocardial infarction was less frequent in the CCTA group compared to ...

Stamford, Connecticut Wednesday, March 12, 2025, 15:00 Hrs [IST] ...

The US Food and Drug Administration (FDA) has given the greenlight to Caristo Diagnostics for CaRi-Plaque, an artificial ...

FDA 510(k) clearance of Caristo's CaRi-Plaque technology advances AI innovator's U.S. commercialization, as it looks to roll out to hospitals, health systems and longevity clinicsThe CaRi-Plaque ...

The CaRi-Plaque technology supports non-invasive analysis of coronary anatomy and pathology from routine coronary computed ...

Bunkerhill Health, a leader in AI-enabled early disease detection, and Cleerly, a pioneer in advanced cardiovascular imaging, ...

Heart disease isn't always obvious, and sometimes you have little to no warning leading up to a catastrophic event.

Coronary artery calcium tests are one the newer tools doctors can use to predict a person's chances of developing cardiovascular problems. "It's a very simple test," Dickerson said. "It's a CT scan ...

Tammy Exum and other state lawmakers were in Hartford Wednesday to raise awareness around coronary ... scans. Is love good for your heart health? The tests measure the amount of calcium in your ...

Vascular deformation mapping is an image analysis technique for mapping 3‐dimensional aortic growth on routine computed tomography angiography (CTA) scans. We aimed to use vascular deformation mapping ...

When coronary computed tomography angiography ... arteries for plaque burden. CCTA is a noninvasive diagnostic test that combines X-ray and other technology to produce detailed, three-dimensional ...